Abstract
Background
Mitral regurgitation volume (MRvol) by quantitative pulsed Doppler (QPD) method previously recommended suffers from geometric assumption error because of circular geometric assumption of mitral annulus (MA). Therefore, the aim of this study was to evaluate the impact of different geometric assumption of MA on the assessment of MRvol by two-dimensional transthoracic echocardiographic QPD method.
Methods
This study included 88 patients with varying degrees of mitral regurgitation (MR). The MRvol was evaluated by QPD method using circular or ellipse geometric assumption of MA. MRvol derived from effective regurgitant orifice area by real time three-dimensional echocardiography (RT3DE) multiplied by MR velocity-time integral was used as reference method.
Results
Assumption of a circular geometry of MA, QPD-MAA4C and QPD-MAPLAX overestimated the MRvol by a mean difference of 10.4 ml (P < 0.0001) and 22.5 ml (P < 0.0001) compared with RT3DE. Assumption of an ellipse geometry of MA, there was no significant difference of MRvol (mean difference = 1.7 ml, P = 0.0844) between the QPD-MAA4C + A2C and the RT3DE.
Conclusions
Assuming that the MA was circular geometry previously recommended, the MRvol by QPD-MAA4C was overestimated compared with the reference method. However, assuming that the MA was ellipse geometry, the MRvol by the QPD-MAA4C + A2C has no significant difference with the reference method.
Keywords: Mitral regurgitation volume, Quantitative pulsed Doppler, Real time three-dimensional echocardiography, Mitral annulus
Introduction
Mitral regurgitation (MR) is one of the most common heart-valve disorder, and its prevalence increases with age [1]. In the clinical decision-making process regarding mitral valvular lesions, accurate determination of the severity of the MR is of major importance [2, 3]. Echocardiography is the first method of non-invasive assessment of MR, and mitral regurgitation volume (MRvol) is an important parameter to evaluate the severity of MR, which may be calculated by quantitative pulsed Doppler (QPD) method as previously recommended [4]. However, this method suffers from geometric limitations of two-dimensional (2D) echocardiography. In the QPD method, important geometric errors are made in calculating the cross-sectional area (CSA) of the mitral annulus (MA) because of the circular geometric assumption (the CSA of MA was derived as 0.785 d2, where d was the diameter of the MA in the apical four-chamber view) [5]. Recently, a series of studies have confirmed that MRvol using effective regurgitant orifice area (EROA) (direct planimetry of EROA by real time three-dimensional color Doppler echocardiography) multiplied by the MR velocity-time integral (VTIMR) was highly accurate [6–8]. Therefore, the aim of this study was to evaluate the impact of different geometric assumption of MA on the assessment of MRvol by the traditional 2D transthoracic echocardiographic (TTE) QPD method, by comparison with MRvol derived from EROA by real time three-dimensional color Doppler echocardiography.
Methods
Study population
This study included 88 patients (55 men, 33 women; mean age, 48.2 ± 14.0 years) with varying degrees of MR of different etiologies on color Doppler echocardiography between October 2011 and August 2017. The etiology of MR was ischemia in 32, idiopathic dilated cardiomyopathy in 26, mitral valve prolapse (MVP) in 30. MVP is diagnosed in the parasternal long-axis view as systolic displacement of the mitral leaflet into the left atrial of at least 2 mm from the MA plane [4]. Exclusion criteria included aortic regurgitation or stenosis, mitral stenosis, atrial fibrillation, frequent atrial or ventricular premature beats, congenital heart disease, hypertrophic cardiomyopathy, and poor general image quality. This study was approved by the institutional review board of The Affiliated Hospital of Qingdao University, and all patients underwent echocardiographic examination because of clinical indications and gave written informed consent.
Echocardiographic examination
2D and real time three-dimensional (3D) echocardiography (RT3DE) were performed using the iE33 ultrasound system (Philips Healthcare, Amsterdam, The Netherlands).
2D TTE: MRvol by QPD method using different geometric assumption of MA
2D TTE was performed with a S5–1 transducer, and patients were imaged in the left lateral decubitus position. The MA diameter was measured between the inner edges of the base of posterior and anterior leaflets in early to mid diastole at maximal mitral valve (MV) opening in the apical four-chamber (A4C), apical two-chamber (A2C) and parasternal long-axis (PLAX) view [5, 9]. The left ventricular outflow tract (LVOT) diameter was measured just below the aortic valve in early to mid systole in the PLAX view [5, 9]. The pulsed Doppler sample was carefully placed as parallel as possible to the blood flow in the A4C and apical five-chamber (A5C) views to obtain the Doppler spectral profiles of the MA and LVOT. The sample volume was positioned at the level of the MA and LVOT. The modal velocity profile on Doppler recordings was traced to obtain the velocity-time integral (VTI) [5, 9]. Data from three cardiac cycles was averaged.
MRvol by QPD was calculated as the difference between MA forward stroke volume (SVMA) and LVOT forward stroke volume (SVLVOT) (Fig. 1), that was MRvol = SVMA - SVLVOT. SVLVOT was calculated as the VTI of LVOT (VTILVOT) multiplied by the cross-sectional area (CSA) of LVOT (CSALVOT). The LVOT is circular and the CSALVOT is derived as: πd2/4, that is 0.785 d2. Thus, SVLVOT = 0.785 d2 × VTILVOT, where d is the diameter of the LVOT in the PLAX view [4].
Fig. 1.
QPD calculations of MRvol assuming that the MA is ellipse geometry. a The diameter of LVOT was measured in the PLAX view, and the CSALVOT was derived as 0.785 d2. d LVOT pulsed Doppler was traced to obtain the VTILVOT. Thus, SVLVOT = 0.785 d2 × VTILVOT = 0.785 × 2.082 × 13.4 = 45.51 ml. b and c The diameter of MA was measured in the A4C and A2C view. The CSAMA was derived as 0.785 × a × b. e MA inflow pulsed Doppler was traced to obtain the VTIMA. Thus, SVMA = 0.785 × a × b × VTIMA = 0.785 × 3.33 × 2.65 × 13.1 = 90.75 ml. In this example of MR, MRvol = SVMA - SVLVOT = 90.75–45.51 = 45.24 ml
SVMA was calculated as the VTI of MA (VTIMA) multiplied by the CSA of MA (CSAMA). Assuming that the MA is circular geometry (Fig. 2), the CSAMA is derived as 0.785 d2. Thus, SVMA = 0.785 d2 × VTIMA, where d was the diameter of the MA in the PLAX, A4C or A2C view. Assuming that the MA is ellipse geometry (Fig. 1), the CSAMA is derived as 0.785 × a × b. Thus, SVMA = 0.785× a × b × VTIMA, where a is the diameter of the MA in A4C and b in A2C view, a in A4C and b in PLAX view or a in A2C and b in PLAX view [4, 10, 11].
Fig. 2.
QPD calculations of MRvol assuming that the MA is circular geometry. a The diameter of LVOT was measured in the PLAX view, and the CSALVOT was derived as 0.785 d2. d LVOT pulsed Doppler was traced to obtain the VTILVOT. Thus, SVLVOT = 0.785 d2 × VTILVOT = 0.785 × 1.962 × 28.8 = 86.85 ml. b and c The diameter of MA was measured in the A4C and A2C view. The CSAA4C was derived as 0.785 × 3.22, and CSAA2C was derived as 0.785 × 2.712. e MA inflow pulsed Doppler was traced to obtain the VTIMA. Thus, SVA4C = 0.785 × 3.22 × 19.2 = 154.33 ml, and SVA2C = 0.785 × 2.712 × 19.2 = 110.69 ml. In this example of MR, MRvol by QPD-MAA4C = SVA4C - SVLVOT = 154.33–86.85 = 67.48 ml, and MRvol by QPD-MAA2C = 110.69–86.85 = 23.84 ml
Real-time 3D color Doppler echocardiograpy: MRvol by RT3DE
3D color Doppler data were acquired immediately after the 2D TTE using the same system equipped with a fully sampled matrix-array X3–1 transducer from the apical view, combining 7 small real-time subvolumes into a larger pyramidal volume. Nyquist limits were set between 40 and 60 cm/sec to avoid any overestimation or underestimation. Patients were asked to hold respiration during imaging acquisition.
Three-dimensional color Doppler data sets were analyzed offline using software (QLAB version 7.1). Using multiplanar reconstruction of the 3D color Doppler data sets, a cross-sectional plane through the vena contracta perpendicular to the jet direction was selected, and the cross-sectional plane was then moved along the jet direction as far as the smallest cross-sectional area [7, 10]. The EROA was determined using manual planimetry of the color Doppler flow signal from an en face view, and the MRvol was calculated as EROA by RT3DE multiplied by the VTIMR (Fig. 3). An MRvol > 60 ml was used to define severe MR [4].
Fig. 3.
MRvol calculated as EROA by RT3DE multiplied by the VTIMR. The 3D color Doppler data was manually cropped by the cross-sectional plane perpendicularly to the regurgitant jet direction up to the smallest cross-sectional area of the regurgitant jet. The EROA was determined using manual planimetry of the color Doppler flow signal from an en face view. Example of a MR patient: EROA = 0.28 cm2, VTIMR = 150 cm, MRvol = 0.28 × 150 = 42 mL
Statistical analysis
Continuous data were presented as mean ± SD. Categorical data were presented as percentages or absolute numbers. One factorial analysis of variance was used to compare the MA diameters measured in different views and the CSAMA calculated using the different geometric assumption. Pearson’s correlation analysis was performed to evaluate the relation between QPD and RT3DE measurements of MRvol. Bland-Altman analysis was performed to evaluate the differences in MRvol assessed with QPD and RT3DE. Differences were considered statistically significant at P < 0.05. Statistical analysis was performed using MedCalc version 15.2 (MedCalc Software, Mariakerke, Belgium).
Results
Clinical and echocardiographic characteristics of the MR patients are listed in Table 1.
Table 1.
Patient characteristics (n = 88)
| Variable | Value |
|---|---|
| Age (y) | 48.2 ± 14.0 |
| Men/women | 55/33 |
| Heart rate (beats/min) | 74.8 ± 13.8 |
| Systolic BP (mm Hg) | 112.5 ± 18.7 |
| Diastolic BP (mm Hg) | 73.1 ± 9.5 |
| LVEDD (cm) | 5.9 ± 1.1 |
| LVESD (cm) | 4.5 ± 1.5 |
| LVEF (%) | 53.1 ± 18.5 |
| LVOT diameter (mm) | 2.0 ± 0.1 |
| VTILVOT (cm) | 17.3 ± 5.0 |
| VTIMA (cm) | 17.9 ± 5.4 |
| VTIMR (cm) | 131.1 ± 29.9 |
| EROA by RT3DE (cm2) | 0.33 ± 0.14 |
BP Blood pressure, LVEDD Left ventricular end-diastolic diameter, LVESD Left ventricular end-systolic diameter, LVEF Left ventricular ejection fraction, EROA by RT3DE The EROA was measured by manual planimetry of the 3D color Doppler signal; Data are expressed as mean ± SD or as number
Comparison of MA diameter in different views and CSAMA based on different geometric assumption
As listed in Table 2, ANOVA showed significant differences among the 2D TTE diameters of the MA in three different views. The MA diameters in PLAX view were larger than the MA diameters in A4C or A2C view (MAPLAX vs MAA4C or MAA2C: 3.0 ± 0.4 vs 2.9 ± 0.4 or 2.7 ± 0.3, P<0.001). As for CSA of the MA, the CSAPLAX derived from circular geometric assumption was larger than CSAA4C and CSAA2C or CSAPLAX + A4C, CSAPLAX + A2C and CSAA4C + A2C derived from ellipse assumption (P<0.001 for all).
Table 2.
Results of ANOVA analysis for MA diameter and CSAMA
| Variable | Value | ANOVA analysis | |
|---|---|---|---|
| F | P | ||
| MA diameter (cm) | |||
| MAPLAX | 3.0 ± 0.4 | 18.471 | <0.001 |
| MAA4C | 2.9 ± 0.4 | ||
| MAA2C | 2.7 ± 0.3 | ||
| Circular assumption (cm2) | |||
| CSAPLAX | 7.1 ± 1.9 | 9.992 | <0.001 |
| CSAA4C | 6.6 ± 1.7 | ||
| CSAA2C | 5.7 ± 1.2 | ||
| Ellipse assumption (cm2) | |||
| CSAPLAX + A4C | 6.8 ± 1.6 | ||
| CSAPLAX + A2C | 6.3 ± 1.4 | ||
| CSAA4C + A2C | 6.1 ± 1.3 | ||
MAPLAX, MAA4Cand MAA2Cdiameter The MA diameter was measured in PLAX, A4C and A2C view, CSAPLAX The CSA of MA was calculated from the MA diameter in PLAX view using circular geometric assumption (CSA = 0.785 d2), CSAPLAX + A4C The CSA of MA was calculated from the MA diameter in PLAX and A4C view using ellipse assumption (CSA = 0.785 × a × b)
Assumption of a circular geometry of MA, MRvol by QPD compared with reference method
Compared with MRvol by RT3DE, MRvol by QPD-MAA4C and QPD-MAA2C showed good correlation (r = 0.822, P < 0.0001; r = 0.805, P < 0.0001), while MRvol by QPD-MAPLAX demonstrated poor correlation (r = 0.574, P < 0.0001). QPD-MAPLAX and QPD-MAA4C overestimated the MRvol by a mean difference of 22.5 ml (P < 0.0001) and 10.4 ml (P < 0.0001) compared with RT3DE (Fig. 4). However, QPD-MAA2C underestimated the MRvol by a mean difference of 5.5 ml (p = 0.0002) compared with RT3DE (Fig. 5).
Fig. 4.
Assumption of a circular geometry of MA, linear regression plot and Bland-Altman plot showing correlations (a) and agreement (b) between MRvol by QPD-MAA4C and RT3DE
Fig. 5.
Assumption of a circular geometry of MA, linear regression plot and Bland-Altman plot showing correlations (a) and agreement (b) between MRvol by QPD-MAA2C and RT3DE
Assumption of a ellipse geometry of MA, MRvol by QPD compared with reference method
MRvol by QPD-MAPLAX + A4C and QPD-MAPLAX + A2C demonstrated good correlation compared with RT3DE(r = 0.789, P<0.0001; r = 0.776, P<0.0001). QPD-MAPLAX + A4C and QPD-MAPLAX + A2C overestimated the MRvol by a mean difference of 15.2 ml (P<0.0001) and 6.8 ml (P = 0.0002) when compared with RT3DE. As for QPD-MAA4C + A2C, there was better correlation compared with RT3DE (r = 0.905, P < 0.0001), and the Bland-Altman analysis revealed no significant difference (mean difference = 1.7 ml, P = 0.0844) (Fig. 6). The correlation and difference between MRvol measured by QPD and RT3DE is summarized in Table 3.
Fig. 6.
Assumption of an ellipse geometry of MA, linear regression plot and Bland-Altman plot showing correlations (a) and agreement (b) between MRvol by QPD-MAA4C + A2C and RT3DE
Table 3.
Results of Pearson’s correlation and Bland-Altman analysis for MRvol by QPD and reference methods
| Method | MRvol (ml) | Pearson’s correlation analysis | Bland-Altman analysis | |||
|---|---|---|---|---|---|---|
| r | p | Mean difference (ml) | 95% limits of agreement (ml) | p | ||
| Circular assumption | ||||||
| QPD-MAPLAX | 66.4 ± 41.1 | 0.574 | <0.0001 | 22.5 | − 43.6 ~ 88.6 | <0.0001 |
| QPD-MAA4C | 54.3 ± 27.6 | 0.822 | <0.0001 | 10.4 | −20.6 ~ 41.4 | <0.0001 |
| QPD-MAA2C | 38.4 ± 20.6 | 0.805 | <0.0001 | −5.5 | −31.7 ~ 20.2 | 0.0002 |
| RT3DE | 43.9 ± 21.3 | |||||
| Ellipse assumption | ||||||
| QPD-MAPLAX + A4C | 59.1 ± 29.5 | 0.789 | <0.0001 | 15.2 | −20.5 ~ 51.0 | <0.0001 |
| QPD-MAPLAX + A2C | 50.6 ± 25.6 | 0.776 | <0.0001 | 6.8 | −24.9 ~ 38.5 | 0.0002 |
| QPD-MAA4C + A2C | 45.6 ± 21.5 | 0.905 | <0.0001 | 1.7 | −16.6 ~ 20.1 | 0.0844 |
QPD-MAPLAX MRvol was measured by QPD using circular geometric assumption, and the MA diameter was measured in PLAX view, QPD-MAPLAX + A4C MRvol was measured by QPD using ellipse assumption, and the MA diameter was measured in PLAX and A4C view, RT3DE MRvol was measured using EROA multiplied by the VTIMR
Categorizations of MR severity according to different methods
On the basis of MRvol by RT3DE, 19 (21.6%) patients had severe MR (MRvol > 60 ml). Assuming that the MA is circular geometry, 42 (47.8%) patients had severe MR based on QPD-MAPLAX, 31 (35.2%) patients had severe MR based on QPD-MAA4C, and 12 (13.6%) patients had severe MR based on QPD-MAA2C. Assuming that the MA is ellipse geometry, 40 (45.4%) patients had severe MR based on QPD-MAPLAX + A4C, 28 (31.8%) patients had severe MR based on QPD-MAPLAX + A2C, and 22 (25%) patients had severe MR based on QPD-MAA4C + A2C.
Compared with MRvol by RT3DE, MR severity using QPD-MAPLAX, QPD-MAA4C, QPD-MAPLAX + A4C, and QPD-MAPLAX + A2C were overestimated in 23 (26.1%) patients, in 12 (13.6%) patients, in 21 (23.8%) patients, and in 9 (10.2%) patients, respectively, and MR severity using QPD-MAA2C was underestimated in 7 (10.2%) patients. Although MR severity using QPD-MAA4C + A2C was overestimated in 3 (3.4%) patients, Chi-squared revealed no significant difference (P = 0.724).
Discussion
The main finding of this study was that compared with the MRvol using EROA by RT3DE multiplied by the TVIMR, the MRvol was overestimated significantly by the 2D TTE QPDA4C method previously recommended [2, 4]. The overestimates were caused by the circular geometric assumption of the MA, which led to the CSA A4C and corresponding SVMA being overestimated. In our study, assumption of an ellipse geometry of MA, MRvol calculated by QPDA4C + A2C showed better correlation (r = 0.905, P < 0.0001) and had no significant difference (mean difference = 1.7 ml, P = 0.0844) with MRvol by RT3DE.
MRvol by QPD is simple in theory. Stroke volume (SV) at aortic valve or MV is derived as the product of CSA and VTI of flow at the LVOT or MA. In the absence of MR, SV determinations at LVOT and MA are equal. In the presence of MR, without any intracardiac shunt, the flow through MA is larger than through the LVOT. The difference between the two represents the MRvol [12]. For MRvol by QPD method, it is very important to accurately evaluate the CSAMA and CSALVOT. The calculation method of CSALVOT is nearly consistent (CSALVOT = πd2/4, where d was the diameter of the LVOT in the PLAX view) [2, 4, 9]. However, the calculation method of CSAMA is controversial [5]. The MA diameter was measured in the A4C view and the CSAMA was derived as 0.785 d2 (where d is the MA diameter in A4C) assuming that the MA is circular geometry as previously recommended [4, 9]. However, previous studies have been demonstrated that the MA has a saddle-shaped contour [13] and the CSA of the MA are oval, with the major and minor diameter [5, 14, 15]. Ren et al. [5] studied geometric errors of the MA by RT3DE. They found that the MA geometry was oval in the 3D en face views with a significant difference between the major and minor diameters. The 2D diameters of the MAA4C was significantly different from both the major and minor diameters. Assuming that the MA was circular geometry, the CSA of the MAA4C by 2D TTE overestimated the CSA compared with RT3DE [5]. In our study, the QPD-MAPLAX and QPD-MAA4C overestimated the MRvol (mean difference = 22.5 ml, P < 0.0001; mean difference = 10.4 ml, P < 0.0001) and QPD-MAA2C underestimated the MRvol (mean difference = 5.5 ml, P = 0.0002) compared with the MRvol by RT3DE. A possible reason is that the 2D MAPLAX and MAA4C diameters may approach the 3D major diameters, and the MAA2C may be close to the 3D minor diameters as previous findings [5, 16]. Based on the assumption of circular geometry, the monoplanar measurements of MA diameter and false geometric assumption are crucial factors of error using the 2D TTE QPD method. This error is important because the MA diameter is squared to derive the CSAMA in the geometric circular assumption formula, which result in an overestimation of the CSAPLAX and CSAA4C and an underestimation of the CSAA2C. Because of these, the corresponding SVMA calculated by CSAPLAX or CSAA4C is overestimated, and the corresponding SVMA calculated by CSAA2C is underestimated. Consequently, the QPD-MAPLAX and QPD-MAA4C overestimated the MRvol and QPD-MAA2C underestimated the MRvol, which may cause over- or underestimation of MR severity. In our present study, compared with MRvol by RT3DE, MR severity using QPD-MAPLAX and QPD-MAA4C were overestimated in 23 (26.1%) patients and in 12 (13.6%) patients, respectively, and MR severity using QPD-MAA2C was underestimated in 7 (10.2%) patients.
Based on that the MA is oval with the major and minor diameters previously demonstrated [5, 14, 15]. In this study, assuming that the MA was ellipse geometry, there was no significant difference of MRvol (mean difference = 1.7 ml, P = 0.0844) between the QPD-MAA4C + A2C and the RT3DE. This is because the MAA4C diameters may approach the 3D major diameters, and the MAA2C may be close to the 3D minor diameters. The CSAMA calculated by 2D MAA2C and MAA4C diameters using ellipse geometric assumption formula (CSAMA = 0.785 × a × b) may be closer to the real CASMA, which led to an accurate evaluation of corresponding SVMA and MRvol by QPD-MAA4C + A2C and may more accurately assess MR severity. In our present study, although MR severity using QPD-MAA4C + A2C was slightly overestimated in 3 (3.4%) patients, Chi-squared revealed no significant difference (P = 0.724). Since the MAPLAX diameter was larger than the MAA4C (3.0 ± 0.4 vs 2.9 ± 0.4, P < 0.001), which resulted in the fact that the CSAPLAX + A2C was larger than the CSAA4C + A2C, the corresponding MRvol by QPD-MAPLAX + A2C was overestimated (mean difference = 6.8 ml, P = 0.0002) compared with the RT3DE. As for the overestimation of MRvol (mean difference = 15.2 ml, P < 0.0001) by QPD-MAPLAX + A4C, this could be related to the fact that the MAA4C diameter was larger than the MAA2C (2.9 ± 0.4 vs 2.7 ± 0.3, P < 0.001), which led to an overestimation of the corresponding CSA PLAX + A4C and SVMA, thus overestimating the MRvol. The smaller difference of the result between the MRvol by QPD-MAA4C + A2C and RT3DE was probably because the MA has an elliptic shape with a saddle-shaped 3D structure, and there are dynamic changes in its shape and position in different diseases during the cardiac cycle [17–20].
Previous study by Lewis JF observed a high correlation between thermodilution- derived stroke volume and Doppler-determined mitral inflow volume, and did not find significant difference between the use of assumption of a circular geometry of MA from the A4C view and the use of assumption of an ellipse geometry of MA from the A4C and A2C views [21]. However, the study by Rokey R found that the average regurgitant volume by the Doppler method (6.04 ± 3.09 l/min), assuming that the MA was circular geometry from the A4C view, was slightly higher than that obtained by angiography (5.33 ± 3.48 l/min), although not significant [22]. Similar results were obtained in study by Enriquez-Sarano M in which the assumption of a circular geometry of MA from the A4C view by the Doppler method mildly overestimated the MA stroke volume and significantly overestimated regurgitant volume [23]. Most of the earlier studies of Doppler method was mainly based on the standard angiographic grading method, which is subjective and influenced by many factors, including catheter position, rhythm disturbances, amount and velocity of dye injected, chamber size, and radiogram penetration [24]. Even the quantitative angiography, which makes use of left ventriculographic stroke volume for mitral valve flow and thermodilution for cardiac output, has conspicuous limitations. The error of cardiac output measurement is between 5 and 10% for thermodilution and between 10 and 15% for angiography, leading to a greater error when they are combined into the MR [24].
Echocardiography is the most commonly method for evaluating MR severity, and the QPD method has been successfully introduced into routine clinical practice for assessment of MR severity [4]. The QPD method is based on accurately evaluating the CSAMA and CSALVOT. The MA diameter was measured in the A4C view and the CSAMA was derived as 0.785 d2 assuming that the MA is circular geometry as previously recommended [4]. Unfortunately, the human left heart and mitral valve do not provide the ideal conditions for the application of assumption of a circular geometry of MA, which eventually diminish the accuracy of assessment of MR severity. Previous studies have been demonstrated that the MA has a saddle-shaped contour and the CSA of the MA are oval [5, 13–15]. Therefore, our aim of the present study is to find the appropriate geometric model and the optimal MA diameters combination for traditional 2D TTE through systematic research, so as to measure the MRvol by 2D TTE QPD more accurately. To the best of our knowledge, no clinical studies have assessed the impact different geometric assumption of MA on the assessment of MRvol by QPD. This study showed that the QPD-MAA4C overestimated the MRvol assuming that the MA was circular geometry as previously recommended, and assuming that the MA is ellipse geometry, the MRvol with QPD-MAA4C + A2C correlated well and had good agreement compared with MRvol using EROA by RT3DE multiplied by the VTIMR. The QPD-MAA4C + A2C provided more accurate assessment of MRvol using ellipse assumption of MA than the QPD-MAA4C applying circular assumption previously recommended.
Limitations
First, a limitation of a true gold standard for calculating MRvol was absent in the present study. In this study, the MRvol derived from EROA by RT3DE multiplied by the VTIMR was used as the reference method, which has been documented as an accurate method [6, 7], and some studies have used it as reference method [10, 25]. However, RT3DE has limited spatial resolution of the reconstructed image, which may lead to biased results [26]. Second, this study did not evaluate the dynamic changes of 3D structure and CSA of the MA in different diseases and cardiac cycles. Third, in this study, the relationship between 3D MA diameters and 2D diameters in different views, as well as the geometry of LVOT were not evaluated, which may add to further errors in calculating MRvol by QPD. Fourth, this present study did not address the significance to stratify the results in primary and secondary MR, and further researches and follow-up data are necessary to explore. Finally, further studies are needed to confirm the results of MRvol by QPD-MAA4C + A2C based on ellipse assumption of MA.
Conclusion
Assuming that the MA is circular geometry as previously recommended, the MRvol by 2D TTE QPD-MAA4C was overestimated compared with the MRvol derived from EROA by RT3DE multiplied by the VTIMR. However, assuming that the MA was ellipse geometry, the MRvol by the 2D TTE QPD-MAA4C + A2C was accurate compared with the reference method.
Acknowledgements
None.
Abbreviations
- 2D
Two-dimensional
- 3D
Three-dimensional
- A2C
Apical two-chamber
- A4C
Apical four-chamber
- A5C
Apical five-chamber
- CSA
Cross-sectional area
- CSAA2C
The CSA of MA was calculated from the MA diameter in A2C view using circular geometric assumption
- CSAA4C
The CSA of MA was calculated from the MA diameter in A4C view using circular geometric assumption
- CSALVOT
CSA of LVOT
- CSAMA
CSA of MA
- CSAPLAX + A2C
The CSA of MA was calculated from the MA diameter in PLAX and A2C view using ellipse assumption
- CSAPLAX + A4C
The CSA of MA was calculated from the MA diameter in PLAX and A4C view using ellipse assumption
- CSAPLAX
The CSA of MA was calculated from the MA diameter in PLAX view using circular geometric assumption
- EROA
Effective regurgitant orifice area
- LVOT
Left ventricular outflow tract
- MA
Mitral annulus
- MAA2C
The diameter of MA was measured in the A2C view
- MAA4C
The diameter of MA was measured in the A4C view
- MAPLAX
The diameter of MA was measured in the PLAX view
- MR
Mitral regurgitation
- MRvol
Mitral regurgitation volume
- MV
Mitral valve
- MVP
Mitral valve prolapse
- PLAX
Parasternal long-axis
- QPD
Quantitative pulsed Doppler
- QPD-MAA2C
MRvol was measured by QPD using circular geometric assumption, and the MA diameter was measured in A2C view
- QPD-MAA4C
MRvol was measured by QPD using circular geometric assumption, and the MA diameter was measured in A4C view
- QPD-MAA4C+A2C
MRvol was measured by QPD using ellipse assumption, and the MA diameter was measured in A4C and A2C view
- QPD-MAPLAX
MRvol was measured by QPD using circular geometric assumption, and the MA diameter was measured in PLAX view
- QPD-MAPLAX+A2C
MRvol was measured by QPD using ellipse assumption, and the MA diameter was measured in PLAX and A2C view
- QPD-MAPLAX+A4C
MRvol was measured by QPD using ellipse assumption, and the MA diameter was measured in PLAX and A4C view
- RT3DE
Real time three-dimensional echocardiography
- SV
Stroke volume
- SVLVOT
LVOT forward stroke volume
- SVMA
MA forward stroke volume
- TTE
Transthoracic echocardiographic
- VTI
Velocity-time integral
- VTILVOT
VTI of LVOT
- VTIMA
VTI of MA
- VTIMR
MR velocity-time integral
Authors’ contributions
WW and XF designed this study as the first author and corresponding author. ZW, JL, and KG were involved in image acquisition and analysis in this study. LZ and GT carried out the statistical analysis. All authors read and approved the final manuscript.
Funding
None.
Availability of data and materials
The data and materials used in this study are available from the corresponding author or the first author on reasonable request.
Ethics approval and consent to participate
This study was approved by the institutional review board of The Affiliated Hospital of Qingdao University, and all patients underwent echocardiographic examination because of clinical indications and gave written informed consent.
Consent for publication
The authors of this study agreed with this manuscript and its submission to Cardiovascular ultrasound.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Wugang Wang, Email: wug1983@sina.com.
Zhibin Wang, Email: qin_wangzhibin@sina.cn.
Junfang Li, Email: qdljf@126.com.
Kun Gong, Email: 15053245868@163.com.
Liang Zhao, Email: 18661803119@163.com.
Guozhang Tang, Email: tangguozhangqdls@163.com.
Xiuxiu Fu, Email: fwanghao@sina.cn.
References
- 1.Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–883. doi: 10.1056/NEJMoa041451. [DOI] [PubMed] [Google Scholar]
- 2.Zoghbi WA, Asch FM, Bruce C, Gillam LD, Grayburn PA, Hahn RT, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2019;32:431–475. doi: 10.1016/j.echo.2019.01.003. [DOI] [PubMed] [Google Scholar]
- 3.Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2017;70:252–289. doi: 10.1016/j.jacc.2017.03.011. [DOI] [PubMed] [Google Scholar]
- 4.Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303–371. doi: 10.1016/j.echo.2017.01.007. [DOI] [PubMed] [Google Scholar]
- 5.Ren B, de Groot-de Laat LE, McGhie J, Vletter WB, Ten Cate FJ, Geleijnse ML. Geometric errors of the pulsed-wave Doppler flow method in quantifying degenerative mitral valve regurgitation: a three dimensional echocardiography study. J Am Soc Echocardiogr. 2013;26:261–269. doi: 10.1016/j.echo.2012.10.011. [DOI] [PubMed] [Google Scholar]
- 6.Little SH, Pirat B, Kumar R, Igo SR, McCulloch M, Hartley CJ, et al. Three dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. JACC Cardiovasc Imaging. 2008;1:695–704. doi: 10.1016/j.jcmg.2008.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Marsan NA, Westenberg JJ, Ypenburg C, Delgado V, van Bommel RJ, Roes SD, et al. Quantification of functional mitral regurgitation by real time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2:1245–1252. doi: 10.1016/j.jcmg.2009.07.006. [DOI] [PubMed] [Google Scholar]
- 8.Shanks M, Siebelink HM, Delgado V, van de Veire NR, Ng AC, Sieders A. et, al. Quantitative assessment of mitral regurgitation: comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging. 2010;3:694–700. doi: 10.1161/CIRCIMAGING.110.947176. [DOI] [PubMed] [Google Scholar]
- 9.Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA, et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167–184. doi: 10.1067/mje.2002.120202. [DOI] [PubMed] [Google Scholar]
- 10.de Agustın JA, Marcos-Alberca P, Fernandez-Golfin C, Gonçalves A, Feltes G, Nuñez-Gil IJ, et al. Direct measurement of proximal isovelocity surface area by single-beat three-dimensional color Doppler echocardiography in mitral regurgitation: a validation study. J Am Soc Echocardiogr. 2012;25:815–823. doi: 10.1016/j.echo.2012.05.021. [DOI] [PubMed] [Google Scholar]
- 11.Thavendiranathan P, Phelan D, Collier P, Thomas JD, Flamm SD, Marwick TH. Quantitative assessment of mitral regurgitation: how best to do it. JACC Cardiovasc Imaging. 2012;5:1161–1175. doi: 10.1016/j.jcmg.2012.07.013. [DOI] [PubMed] [Google Scholar]
- 12.Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777–802. doi: 10.1016/S0894-7317(03)00335-3. [DOI] [PubMed] [Google Scholar]
- 13.Levine RA, Handschumacher MD, Sanfilippo AJ, Hagege AA, Harrigan P, Marshall JE, et al. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation. 1989;80:589–598. doi: 10.1161/01.CIR.80.3.589. [DOI] [PubMed] [Google Scholar]
- 14.Anwar AM, Soliman OI, Nemes A, Germans T, Krenning BJ, Geleijnse ML, et al. Assessment of mitral annulus size and function by real-time 3-dimensional echocardiography in cardiomyopathy: comparison with magnetic resonance imaging. J Am Soc Echocardiogr. 2007;20:941–948. doi: 10.1016/j.echo.2007.01.026. [DOI] [PubMed] [Google Scholar]
- 15.Anwar AM, Soliman OI, ten Cate FJ, Nemes A, McGhie JS, Krenning BJ, et al. True mitral annulus diameter is underestimated by two-dimensional echocardiography as evidenced by real-time three-dimensional echocardiography and magnetic resonance imaging. Int J Cardiovasc Imaging. 2007;23:541–547. doi: 10.1007/s10554-006-9181-9. [DOI] [PubMed] [Google Scholar]
- 16.Foster GP, Dunn AK, Abraham S, Ahmadi N, Sarraf G. Accurate measurement of mitral annular dimensions by echocardiography: importance of correctly aligned imaging planes and anatomic landmarks. J Am Soc Echocardiogr. 2009;22:458–463. doi: 10.1016/j.echo.2009.02.008. [DOI] [PubMed] [Google Scholar]
- 17.Kaplan SR, Bashein G, Sheehan FH, Legget ME, Munt B, Li XN, et al. Three-dimensional echocardiographic assessment of annular shape changes in the normal and regurgitant mitral valve. Am Heart J. 2000;139:378–387. doi: 10.1016/S0002-8703(00)90077-2. [DOI] [PubMed] [Google Scholar]
- 18.Daimon M, Gillinov AM, Liddicoat JR, Saracino G, Fukuda S, Koyama Y, et al. Dynamic change in mitral annular area and motion during percutaneous mitral annuloplasty for ischemic mitral regurgitation: preliminary animal study with real-time 3-dimensional echocardiography. J Am Soc Echocardiogr. 2007;20:381–388. doi: 10.1016/j.echo.2006.08.029. [DOI] [PubMed] [Google Scholar]
- 19.Jolley MA, Ghelani SJ, Adar A, Harrild DM. Three-dimensional mitral valve morphology and age-related trends in children and young adults with structurally normal hearts using transthoracic echocardiography. J Am Soc Echocardiogr. 2017;30:561–571. doi: 10.1016/j.echo.2017.01.018. [DOI] [PubMed] [Google Scholar]
- 20.Chen TE, Ong K, Suri RM, Enriquez-Sarano M, Michelena HI, Burkhart HM, et al. Three-dimensional echocardiographic assessment of mitral annular physiology in patients with degenerative mitral valve regurgitation undergoing surgical repair: comparison between early- and late-stage severe mitral regurgitation. J Am Soc Echocardiogr. 2018;31:1178–1189. doi: 10.1016/j.echo.2018.07.005. [DOI] [PubMed] [Google Scholar]
- 21.Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA. Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation. 1984;70:425–431. doi: 10.1161/01.CIR.70.3.425. [DOI] [PubMed] [Google Scholar]
- 22.Rokey R, Sterling LL, Zoghbi WA, Sartori MP, Limacher MC, Kuo LC, et al. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol. 1986;7:1273–1278. doi: 10.1016/S0735-1097(86)80146-2. [DOI] [PubMed] [Google Scholar]
- 23.Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ, Krohn MJ, Mays JM. Quantitative Doppler assessment of valvular regurgitation. Circulation. 1993;87:841–848. doi: 10.1161/01.CIR.87.3.841. [DOI] [PubMed] [Google Scholar]
- 24.Chen CG, Thomas JD, Anconina J, Harrigan P, Mueller L, Picard MH, et al. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation. Circulation. 1991;84:712–720. doi: 10.1161/01.CIR.84.2.712. [DOI] [PubMed] [Google Scholar]
- 25.Wang W, Lin Q, Wu W, Jiang Y, Lan T, Wang H. Quantification of mitral regurgitation by general imaging three-dimensional quantification: feasibility and accuracy. J Am Soc Echocardiogr. 2014;27:268–276. doi: 10.1016/j.echo.2013.11.015. [DOI] [PubMed] [Google Scholar]
- 26.Zeng X, Levine RA, Hua L, Morris EL, Kang Y, Flaherty M, et al. Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D-echocardiography. Circ Cardiovasc Imaging. 2011;4:506–513. doi: 10.1161/CIRCIMAGING.110.961649. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data and materials used in this study are available from the corresponding author or the first author on reasonable request.






